Consensus statement: Palliative and supportive care in advanced heart failure

Journal of Cardiac Failure

Volumn 10, Issue 3, 2004, Pages 200-209

  Goodlin, Sarah J ^a,s   Hauptman, Paul J ^b   Arnold, Robert ^c   Grady, Kathleen ^d   Hershberger, Ray E ^e   Kutner, Jean ^f   Masoudi, Frederick ^g   Spertus, John ^h   Dracup, Kathleen ⁱ   Cleary, James F ^j   Medak, Ruth ^k   Crispell, Kathy ^l   Piña, Ileana ^m   Stuart, Brad ⁿ   Whitney, Christy ^o   Rector, Thomas ^p   Teno, Joan ^q   Renlund, Dale G ^r  

^a Institute for Health Care Delivery Research   (United States)

^b SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g DENVER HEALTH MEDICAL CENTER   (United States)

^h SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF WISCONSIN MADISON   (United States)

^k Oregon Medical Professional Review Organization   (United States)

^l PORTLAND VA MEDICAL CENTER   (United States)

^m UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁿ Sutter VNA and Hospice   (United States)

^o Hospice Palliative Care W Colorado   (United States)

^p UNITEDHEALTH GROUP   (United States)

^q BROWN UNIVERSITY   (United States)

^r LDS HOSPITAL   (United States)

^s INTERMOUNTAIN HEALTHCARE   (United States)

more..

Author keywords

advanced heart failure; palliative care

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PSYCHOSTIMULANT AGENT;

CONSENSUS DEVELOPMENT; COST BENEFIT ANALYSIS; DECISION MAKING; DEPRESSION; DYSPNEA; FATIGUE; HEART FAILURE; HOSPICE CARE; HUMAN; INTERDISCIPLINARY COMMUNICATION; OXYGEN SUPPLY; PALLIATIVE THERAPY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 3042706745     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.09.006     Document Type: Article

References (64)

1. Gorkin L, Norvell N.K, Rosen R.C, Charles E, Shumaker S.A, McIntyre K.M, et al. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial. Am J Cardiol. 71:1993;1069-1073
2. Dracup K, Walden J.A, Stevenson L.W, Brecht M. Quality of life with advanced heart failure. J Heart Lung Transplant. 11:1992;273-279
3. Murray S.A, Boyd K, Kendall M, Worth A, Benton T.F, Calusen H. Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their careers in the community. BMJ. 325:2002;929-934
4. Linne A.B, Liedholm H, Jendteg S, Israelsson B. Health care costs of heart failure: results from a randomized study of patient education. Eur J Heart Fail. 2:2002;291-297
5. American Heart Association. Heart disease and stroke statistics - 2003 update. Available from: http://www.myamericanheart.com.
6. Ho K.K.L, Pinsky J.L, Kannel W.B, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 22:(S):1993;6A-13A
7. Hunt S.A, Baker D.W, Chin M.H, Cinquegrani M.P, Feldman A.M, Francis G.S, et al. American College of Cardiology/American Heart Association guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Amer Col Cardiol. 38:2001;2101-2113
8. Grady K.L, Meyer P, Mattea A, White-Williams C, Ormaza S, Kaan A, et al. Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J Heart Lung Transplantation. 20:2001;657-669
9. Grady K.L, Jalowiec A, White-Williams C, Pifarre R, Kirklin J.K, Bourge R.C, et al. Predictors of quality of life in patients with advanced heart failure awaiting transplantation. J Heart Lung Transplant. 14:1995;2-10
10. Walden J.A, Stevenson L.W, Dracup K, Hook J.F, Moser D.K, Hamilton M, et al. Extended comparison of quality of life between stable heart failure patients and heart transplant recipients. J Heart Lung Transplant. 13:1994;1109-1118
11. Stanek E.J, Oates M.B, McGhan W.F, Denofrio D, Loh E. Preferences for treatment outcomes in patients with heart failure: symptoms versus survival. J Card Fail. 6:2000;225-232
12. Kutner J.S, Kassner C.T, Nowels D.E. Symptom burden at the end of life: hospice providers' perceptions. J Pain Symptom Manage. 21:2001;473-480
13. Rich M.W. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 45:1997;968-974
14. Masoudi F.A, Havranek E.P, Krumholz H.M. The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research. Heart Failure Rev. 7:2002;9-16
15. The National Center for Health Statistics. Second Supplement on Aging. 1994;Author, Hyattsville (MD)
16. National Center for Health Statistics. Health, United States, 1999, with health and aging chartbook. 1999;National Center for Health Statistics, Hyattsville (MD)
17. National Mortality Follow back Survey. National Center for Health Statistics, Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/nchs/about/major/nmfs/nmfs.htm. Accessed January 2, 2004.
18. Lynn J. An 88-year-old woman facing the end of life. JAMA. 277:1997;1633-1640
19. Heiat A, Gross C.P, Krumholz H.M. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 162:2002;1682-1688
20. Rose E.A, Gellins A.C, Moskowitz A.J, Heitjan D.F, Stevenson L.W, Dembitsky W, et al., for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 345:2001;1435-1443
21. Mancini D, Nonan N, Ascheim D, Renlund D, et al. Predictors of survival in patients with end stage heart failure. Circulation. S-II:2002;601
22. Hershberger R.E, Nauman D, Walker T.L, Dutton D, Burgess D. Care processes and clinical outcomes of Continuous Outpatient Support with Inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail. 9:2003;180-187
23. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, van Scheidt W, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 38:2001;1934-1941
24. Gottlieb S.S, Abraham W, Butler J, Forman D.E, Loh E, Massie B.M, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 8:2002;136-141
25. Chatterjee K. Heart failure therapy in evolution. Circulation. 94:1996;2689-2693
26. Murberg T.A, Bru E, Svebak S, Tveteras R, Aarsland T. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow-up study. Int J Psych Med. 29:1999;311-326
27. Sullivan M, Simon G, Spertus J, Russo J. Depression-related costs in heart failure care. Arch Intern Med. 162:2002;1860-1866
28. Faris R, Purcell H, Henein M.Y, Coats A.J. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail. 4:2002;541-551
29. Goldman L, De Marco T. Predicting outcomes in severe heart failure. Circulation. 95:1997;2597-2599
30. Stuart B, Alexander C, Arenella C, Connor S, Herbst L, Jones D, for Standards and Accreditation Committee, Medical Guidelines Task Force. Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases. 1996;National Hospice Organization, Arlington (VA)
31. Anderson F, Downing G.M, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Pall Care. 12:1996;5-11
32. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacological approaches. J Card Fail. 5:1999;357-382
33. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 325:1991;293-302
34. Farrell M.H, Foody J.M, Krumholz H.M. β-blockers in heart failure, clinical applications. JAMA. 287:2002;890-897
35. Krum H, Roecker E.B, Mohacsi P, Rouleau J.L, Tendera M, Coats A.J, et al. Effects of initiating carvedilol in patients with severe chronic heart failure; results from the COPERNICUS Study. JAMA. 289:2003;712-789
36. Köhnlein T, Welte T, Tan L.B, Elliott M.W. Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax. 57:2002;547-554
37. Lenique F, Habis M, Lafaso F, Dubois-Randle J.L, Harf A, Brochard L, et al. Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure. Am J Respir Crit Care Med. 155:1997;500-505
38. Naughton M.T, Benard D.C, Liu P.P, Rutherford R, Rankin F, Bradley T.D. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 152:1995;473-479
39. Russell S.D, Koshkarian G.M, Medinger A.E, Carson P.E, Higginbotham M.B. Lack of effect of increased inspired oxygen concentrations on maximal exercise capacity or ventilation in stable heart. Am J Cardiol. 84:1999;1412-1416
40. Zeppetella G. The palliation of dyspnea in terminal disease. Am J Hospice Palliat Care. 15:1998;322-330
41. Jennings A.L, Davies A.N, Higgins J.P.T, Gibbs J.S.R, Broadley K.E. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 57:2002;939-944
42. Uretsky B.F, Jessup M, Konstam M.A, Dec G.W, Leier C.V, Benotti J, et al. Multicenter trial or oral enoximone in patients with moderate to moderately sever congestive heart failure: lack of benefit compared to placebo. Circulation. 82:1990;774-780
43. Kubo S.H. Effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Cardiology. 88:1997;21-27
44. Lowes B.D, Higginbotham M, Petrovich L, De Wood M.A, Greenberg M.A, Rahko P.S, et al. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. J Amer Coll Cardiol. 36:2000;501-508
45. Grady K.L, Dracup K, Kennedy G, Moser D.K, Piano M, Stevenson L.W, et al. Team management of patients with heart failure: a statement for healthcare professionals from the Cardiovascular Nursing Council of the American Heart Association. Circulation. 102:2000;2443-2456
46. Hunt S.A. Current status of cardiac transplantation. JAMA. 280:1998;1692-1698
47. Moss A.J, Zareba W, Hall W.J, Klein H, Wilber D.J, Cannom D.S, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 346:2002;877-883
48. Stevenson L.W. Rites and responsibilities for resuscitation in heart failure, tread gently on the thin places. Circulation. 98:1998;619-622
49. Abraham W.T, Fisher W.G, Smith A.L, Delurgio D.B, Leon A.R, Loh E, et al. MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. N Engl J Med. 346:2002;1845-1853
50. Young J.B, Abraham W.T, Smith A.L, Leon A.R, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA. 289:2003;2685-2694
51. Martensson J, Dracup K, Fridlund B. Decisive situations influencing spouses' support of patients with heart failure: a critical incident technique analysis. Heart Lung J Acute Crit Care. 30:2001;341-350
52. Evangelista L.S, Dracup K, Doering L, Westlake C, Fonarow G.C, Hamilton M. Emotional well-being of heart failure patients and their caregivers. J Card Fail. 8:2002;300-305
53. Walden J.A, Dracup K, Westlake C, Erickson V, Hamilton M.A, Fonarow G.C. Educational needs of patients with advanced heart failure and their caregivers. J Heart Lung Transplant. 20:2001;766-769
54. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). JAMA. 274:1995;1591-1598
55. Teno J.M, Fisher E.S, Hamel M.B, Coppola K, Dawson N.V. Medical care inconsistent with patients' treatment goals: association with 1-year medicare resource use and survival. J Am Geriatr Soc. 50:2002;496-500
56. Rector T.S, Tschumperlin L.K, Kubo S.H, Bank A.J, Francis G.S, McDonald K.M, et al. Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail. 1:1995;201-206
57. Teno J.M, Lynn J. Putting advance-care planning into action. J Clin Ethics. 7:1996;205-213
58. Foley K.M. The World Health Organization program in cancer pain relief and palliative care. Gebhart G.I, Hammond D.L, Jensen T.S. Proceedings of the 7th World Congress on Pain: Progress in Pain Research and Management. Vol. 2. 1994;59-74 IASP Press, Seattle (WA)
59. Committee on Quality Health Care in America. Crossing the quality chasm: a new health system for the 21st century. 2001;National Academy Press, Washington, D.C
60. Lewis E.F, Johnson P.A, Johnson W, Collins C, Griffin L, Stevenson L.W. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 20:2001;1016-1024
61. Krumholz H.M, Phillips R.S, Hamel M.B, Teno J.M, Bellamy P, Broste S.K, et al., for the SUPPORT Investigators. Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT Project. Circulation. 98:1998;648-655
62. Back A, Arnold R.M, Quill T. Hoping for the best, preparing for the worst. Ann Int Med. 138:2003;439-444
63. Butow P.N, Hagerty R, Tattersall M.H.N. Communicating prognosis to patients with metastatic disease: what do they really want to know? Supportive Care Cancer. 10:2002;161-168
64. Finucane T.E. Care of patients nearing death: another view. J Am Geriatr Soc. 50:2002;551-553